FIELD: medicine. SUBSTANCE: innovation deals with medicinal preparation affecting tissue metabolism and representing polyenzymatic product. The suggested preparation named Ferestal is designed in tabletted form. Tablet's center contains pancreatin, hemicellulose, extract of bovine bile, polyvinylpyrrolidone, sodium chloride and calcium stearate; as for tablet's membrane, it includes sodium chloride, acetylphthalylcellulose, ethylvaniline, castor oil, calcium carbonate, talc, gelatin, glucose syrup or liquid glucose, gum arabic, nipagin, nipasol, titanium dioxide, capol and saccharose (sugar). Ferestal provides multi-purpose action upon a body at gastrointestinal disorders being nontoxic at usage. EFFECT: higher efficiency. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING THE CASES OF PANCREAS DISEASES AND DIGESTION DISORDERS RELATED TO HEPATIC DISEASES | 2004 |
|
RU2276985C1 |
MEDICINAL AGENT FOR TREATMENT OF PATIENTS WITH DECREASED EXTERNALLY SECRETORY PANCREAS FUNCTION | 1994 |
|
RU2068698C1 |
MEDICINAL AGENT "GASTROPEK" FOR IMPROVING DIGESTION PROCESS AND METHOD FOR ITS USING | 2004 |
|
RU2276974C2 |
"PANZYM FORTE" ENZYMATIC PREPARATION | 2002 |
|
RU2225724C1 |
PREPARATION FOR GASTROENTERIC ENZYMOPATHY TREATMENT | 1992 |
|
RU2057538C1 |
PHARMACEUTICAL COMPOSITION USING IN PANCREAS DISEASES | 2002 |
|
RU2207847C1 |
SPASMOLYTIC TABLETS BRALANGIN | 2001 |
|
RU2203041C1 |
MEDICINAL AGENT SHOWING REGENERATING AND WOUND-HEALING ACTION | 2000 |
|
RU2191574C2 |
ANTIBACTERIAL AGENT "BRIFESEPTOL" | 2001 |
|
RU2199324C1 |
MEANS FOR ISCHEMIA TREATMENT, METHOD FOR ITS PRODUCTION AND METHOD FOR ISCHEMIA TREATMENT (VERSIONS) | 2015 |
|
RU2620163C2 |
Authors
Dates
2003-04-10—Published
2001-12-29—Filed